<h2>Patient Guide</h2>
<h3>Watch video guides to help your patients set up and use My Dose Coach App.</h3>
<p>Arabic videos can be available upon request. Please email: <a href="mailto:mydosecoach@mmscarabia.net"><u>mydosecoach@mmscarabia.net</u></a></p>

<h2>How do patients set up the My Dose Coach App</h2>

INTEGRATED-DIABETES-CARE

DIABETES

My Dose Coach - Patient Guide

<h2>How do patients use the My Dose Coach App every day<span>&nbsp;</span></h2>

<h2>How do patients enter a low blood sugar in the My Dose Coach App</h2>

<h2>Download My Dose Coach App for Patients</h2>
<p>Scan the QR code or click on the App Store Links or share the links with your patients to download My Dose Coach App.</p>

<h2>Get Started With My Dose Coach For HCPs</h2>
<p>&nbsp;<strong>Register in My Dose Coach Program through:</strong></p>
<ul>
 <li>Email:&nbsp;<a href="mailto:mydosecoach@mmscarabia.net"><u>mydosecoach@mmscarabia.net</u></a></li>
 <li>What’s App:&nbsp;<a href="tel:+966554673579"><u>+966554673579</u></a></li>
</ul>

<p><strong>For Technical Support, please contact call-center:</strong></p>
<ul>
 <li>Saudi Arabia - Toll Free Number 800 124 0226</li>
 <li>Kuwait - Phone Number +96 522 068960</li>
</ul>
<p>My Dose Coach is not intended to replace the care or advice of a healthcare team<br>
  My Dose Coach is approved in Saudi Arabia under authorization number: GHTF-2020-2084</p>

<h2>About My Dose Coach (MDC)</h2>
<h3>Empower Your Patients Taking Once Daily Long-Acting Basal Insulin To Self-Adjust Their Insulin Doses In Between Visits, With</h3>

<p>My Dose Coach Provides you with an easy way to manage and monitor your patients’ dose plans</p>

<p>Provides patients with dose recommendations to help them work towards their target fasting blood glucose levels</p>

<p>Is easily customizable, allowing you to individualize patient dose plans according to your usual practice of medicine</p>

<h2>How My Dose Coach Would Help You?</h2>

<p>My Dose Coach web portal allows you to easily prescribe and send a custom dose plan for your patients taking basal insulin.</p>

Prescribe a Dose Plan

black

<p>Your patient needs to record their daily fasting blood glucose readings and insulin dose administered in the My Dose Coach app to start getting insulin dose recommendations based on your prescribed dose plan.</p>

Help Your Patient Stay On Track With Their Insulin Dose Plan

<p>You can review your patient’s blood glucose and insulin dose data in the My Dose Coach web portal to follow your patient’s progress.</p>
<p>My Dose Coach May Enhance Communication Between You and Your Patients</p>

Manage and Monitor Your Patient’s Dose Plan

<h3>Getting Started</h3>
<p>To get patients set up on My Dose Coach, you simply need to:</p>
<ol>
 <li>Register the patient in My Dose Coach web portal</li>
 <li>Prescribe a dose plan<br>
   &nbsp;</li>
</ol>
<ul>
 <li>Train the patient on how to use My Dose Coach App</li>
</ul>

<h3>Support and Monitor</h3>
<ul>
 <li>
  <p>Support materials can help you train your patients</p></li>
 <li>In the “Patient History” section you can review your patient’s therapy progress and decide if modifications are needed</li>
</ul>

<h2>How My Dose Coach Would Help Your Patients?</h2>

<h3>Helps Your Patients To Adjust Their Basal Insulin Dose According To Your Instructions Through An Easy-To-Use Two Steps A Day Application:</h3>

<p>1. Patients check and record their fasting blood glucose as often as directed by you.</p>

<p>2. Patients check the app at the time of injection to receive insulin dose recommendations.</p>

<h2>With My Dose Coach App, Patients Can:</h2>

<p>1. Track their blood glucose levels and insulin doses in the “History” section; or consult their dose plan in the “Summary of instructions”.</p>

<p>2. Find helpful resources on how to manage basal insulin therapy and use My Dose Coach app successfully.</p>

Register your clinic in My Dose Coach HCP Platform

My Dose Coach - About MDC

<h2>Effectiveness of myDose Coach&nbsp;MDC-assisted basal insulin titration in People with Type 2 Diabetes in Saudi Arabia and Kuwait*</h2>

<h3>Results</h3>
<div>
 <table border="1" cellpadding="1" cellspacing="1" style="width:100%;">
  <tbody>
   <tr>
    <td>
     <p>Among PWT2D in&nbsp;<strong>Saudi Arabia and Kuwait</strong>, use of My Dose Coach™&nbsp;with Toujeo led to a&nbsp;<strong>Better Glycemic Control with Low Risk of Hypoglycemia;</strong></p>
     <p>The best glycemic outcomes were observed with high versus moderate or low usage of the app</p></td>
   </tr>
  </tbody>
 </table>
</div>

Reference

<h3>Launch of NEW VERSION of my Dose Coach</h3>

<h3>Patient 360 View</h3>
<h4>You can review &amp; monitor your patient's progress in a Dynamic Chart</h4>

<h3>Simply One Click action to manage your patients</h3>

<h3>Clinic View</h3>
<h4>Clinic dashboard is designed to highlight your patients who deserve your major attention</h4>

<h3>Export Medical Records</h3>
<h4>To be integrated to patient's hospital file</h4>

<h2>cBGM Integration - Pairing Process</h2>

<h2>cBGM Integration – Automated BG data entry</h2>

<h2>Register your clinic in My Dose Coach HCP Platform</h2>

My Dose Coach

<h2>Effectiveness of My Dose Coach™ (MDC)-assisted basal insulin titration in People with Type 2 Diabetes in Saudi Arabia and Kuwait*</h2>

<h2>Objective</h2>
<p>Evaluate the real-world effectiveness of the MDC app among PWT2D in Saudi Arabia and Kuwait, using Toujeo, measured by&nbsp;<strong>achievement of FBG target, change in FBG, and rate of hypoglycemia</strong></p>

<h2>Study design</h2>
<p>A retrospective observational cohort analysis included people with T2D who were registered for MDC by their HCP between 5/2021-8/2022 and received Toujeo. Outcomes were also analyzed based FBG goal status (achieved target; still titrating; stopped using MDC) and on MDC usage (high: &gt;3 days per week; moderate: ≥1–≤3 days per week; low: ≤1 day per week)</p>

<h2>Results</h2>
<p>Overall,&nbsp;<strong>58.9%&nbsp;</strong>of users achieved their individualized FBG target. Mean (SD) time to reach FBG was 16.3 (20.8) days&nbsp;<strong>91.2%</strong>&nbsp;of patients with high MDC usage achieved their FBG target, with a mean (SD) time of 14.8 (19.4) days to reach target, compared with 24.5% of patients with moderate usage (mean time 29.4 [28.4] days).</p>

<h2>Conclusion</h2>
<p>Among PWT2D in Saudi Arabia and Kuwait,&nbsp;<strong>use of My Dose Coach™ led to a better glycemic control with low risk of hypoglycemia</strong>; the best glycemic outcomes were observed with high versus moderate or low usage of the app</p>

<h2>Clinical Evidence and Safety</h2>
<h3>My Dose Coach Effıcacy Has Been Demonstrated In RWE Studies¹⁻³</h3>

<h3>Effectiveness of MDC in Achieving Self Measured Plasma Glucose &amp; Improving Well - Being Index<sup>6</sup></h3>

<p>In a 16-week, real-world study conducted in outpatients in Mexico, My Dose Coach was helpful in achieving FBG goals and reducing A1c with no event of severe hypoglycemia<sup>6</sup></p>

<p>In the same study, use of My Dose Coach was effective in helping patients to achieve Self Measured Plasma Glucose goals and increase their Well Being Index&nbsp;<sup>6</sup></p>

<p>MDC= My Dose Coach<br>
  SMPG=Self Measured Plasma Glucose<br>
  FBG=Fasting Blood Glucose</p>

References

<h2>Safety</h2>
<h3>Empower Your Patents To Safely Adjust Their Basal Insulin Between Clinic Visits, With</h3>

<h3>Studies Have Shown That Patient-Led Titration Of Basal Insulin With My Dose Coach, And Other Digital Titration Tools, Can Help Patients Achieve Their Glycemic Goals Without Increased Risk Of Severe Hypoglycemia.<sup>1-4</sup></h3>

<h2>Improved Quality Of Life</h2>
<p>Patients in the INNOVATE study using a digital home-based titration tool experienced improved psychosocial outcomes with reductions in emotional burden and regimen distress (on the diabetes distress score), as well as no increase in the fear of hypoglycemia (on the hypoglycemia fear score).<sup>5</sup></p>

My Dose Coach - Real World Evidence

<h2>Objectives</h2>
<p>To compare the efficacy in achieving the fasting self-monitoring plasma glucose (SMPG) Target of 90-130 mg/dL, between two insulin glargine titration methods: My Dose Coach<sup>TM</sup>&nbsp;app with remote real-time settings (MDC) and conventional strategy (CS) with face-to- face insulin dose modifications every 2 weeks.</p>

<h2>In this analysis of the impact of My Dose Coach<sup>TM</sup>&nbsp;use…</h2>

<p style="text-align: center;"><strong>A) Proportion of My Dose Coach<sup>TM</sup>&nbsp;users<br>
   achieving FBG target</strong></p>

<p style="text-align: center;"><strong>B) Time to FBG target achievement</strong><br>
  &nbsp;</p>

<p style="text-align: center;"><strong>C) FBG change, in different app usage<br>
   frequency groups</strong></p>

<h2>Conclusion</h2>
<h3>Higher My Dose Coach<sup>TM</sup>&nbsp;usage was associated with:</h3>

<p style="text-align: center;"><strong>Better FBG target achievement</strong><br>
  &nbsp;</p>

<p style="text-align: center;"><strong>Shorter time to FBG target</strong><br>
  &nbsp;</p>

<p style="text-align: center;"><strong>Greater reduction from baseline FBG</strong></p>

<p>Hypoglycemia risk did not change with increased frequency of My Dose Coach<sup>TM</sup>&nbsp;usage</p>
<ul>
 <li>People with T2D initiating BI using My Dose Coach<sup>TM</sup>&nbsp;&gt;3 days/ week during titration had better glycemic outcomes than those with lower usage, with no increase in hypoglycemia</li>
 <li>These results suggest that use of My Dose Coach<sup>TM</sup>&nbsp;may help people with T2D manage their disease by appropriately titrating their BI dose to achieve glycemic targets; such a personal application may also encourage patient participation in managing their condition</li>
</ul>

<h2>Method</h2>
<ul>
 <li>This retrospective observational cohort analysis included people with T2D who were registered for My Dose Coach<sup>TM</sup>&nbsp;by their HCP between 8/1/2018 – 4/30/2020 and received BI</li>
 <li>Study outcomes included change in FBG, change in insulin dose, occurrence of hypoglycemia (defined as FBG below the HCP defined hypoglycemia cut-off per the titration plan), usage of My Dose Coach<sup>TM</sup>, percentage of users achieving FBG target, and time to achieving FBG target</li>
 <li>Users were trained to record FBG and administered BI doses directly in My Dose Coach<sup>TM</sup>. Users with an activated care plan and ≥ 2 FBG observations spanning at least 2 weeks (active users) were selected for analysis</li>
 <li>Users who logged ≥ 3 consecutive FBG measurements within their prescribed target range were defined as reaching titration target (specified by the HCP during care plan creation)</li>
</ul>

<p>My Dose Coach is not intended to replace the care or advice of a healthcare team<br>
  My Dose Coach is approved in Saudi Arabia under authorization number: GHTF-2020-2084</p>

Impact of the Frequency of My Dose CoachTM Use on Clinical Outcomes in Type 2 Diabetes

<h2>HCP Guide</h2>
<h3>Watch video guides to help you understand on how to prescribe patient dose plan, create a dose plan template and monitor patient's progress with My Dose Coach.</h3>

My Dose Coach - Getting Started

<h3>Monitor Patients’ progress &amp; Adjust dose plan</h3>

<h2>Get Started With My Dose Coach For HCPs</h2>
<p>&nbsp;<strong>Register in My Dose Coach Program through:</strong></p>
<ul>
 <li>Email:&nbsp;<a href="mailto:mydosecoach@mmscarabia.net"><span style="color:#0000ee;"><u>mydosecoach@mmscarabia.net</u></span></a></li>
 <li>What’s App:&nbsp;<a href="https://api.whatsapp.com/message/WGUA4P3ALHBAA1" target="_blank"><span style="color:#0000ee;"><u>+966554673579</u></span></a></li>
</ul>

<p><strong>For Technical Support, please contact call-center:</strong></p>
<ul>
 <li>Saudi Arabia - Toll Free Number 800 124 0226</li>
 <li>Kuwait - Phone Number +96 522 068960</li>
</ul>

<h2>What If You Could Help Your Patients Using Once Daily Long-Acting Basal Insulin Safely Adjust Their Dose In Between Visits?</h2>
<h3>Suboptimal Basal-Insulin Titration Has Important Cost And Clinical Implications; Titration May Need To Be Repeated Due To Disease Progression¹</h3>

<h2>Importance Of Titration Period:</h2>
<h3>Treatment Discontinuation Often Occurs Soon After Insulin Initation<sup>9</sup></h3>

<p data-font="legal">*ER – Emergency Room</p>

<h3>My Dose Coach: Titrate with Confidence</h3>
<h4>Watch the video to learn on how to achieve more glycemic control for your patients with My Dose Coach</h4>

My Dose Coach - Self Titration

My Dose Coach - Register your Clinic

<h2>U.S-FDA approved inpatient and outpatient technology-based solutions for effective insulin dose management for people with diabetes</h2>
<p>This review focuses on U.S. Food and Drug Administration (FDA) approved products designed to aid insulin dosing (inpatient/outpatient settings).</p>

<h2>Key Takeaway</h2>
<p>Diabetes care is well suited for virtual/remote care:</p>
<ul>
 <li>Insulin dosing technology integrated with electronic medical record (EMR) supports clinicians in glucose management in the hospital setting, and app-based systems assist insulin dose adjustments at home.</li>
 <li>Inpatient and outpatient digital solutions can serve as educational tools in the academic settings, particularly for insulin initiation and titration.</li>
 <li>Appropriate usage of inpatient/outpatient insulin management technologies aids effective self-management of diabetes by the patients, reduces the economic burden, and assists health care providers (HCPs) in communicating with the patients efficiently.</li>
 <li>New technologies with computer algorithms improve health outcomes by overcoming barriers associated with insulin initiation/titration/adherence.</li>
 <li>With the availability of mobile apps for insulin management and other digital solutions that remotely transmit glucose monitoring results, diabetes care is well adapted for the novel coronavirus pandemic situation.</li>
</ul>

<h2>Why This Matters</h2>
<ul>
 <li>Diabetes and associated complications increase the economic burden on the U.S. health care system, emphasizing the need for effective diabetes management.</li>
 <li>Despite significant advances in drug development, people with diabetes and their HCPs find it difficult to achieve guidelinerecommended A1C goals, making improvisation/digitalization of insulin-management essential.</li>
</ul>

<h2>Key Results</h2>
<p>Inpatient electronic glucose management systems to manage insulin doses: These programs support clinical reasoning but do not substitute for it</p>
<ul>
 <li>Glucommander (Glytec): Uses evidence-based multivariate algorithms: (1) offers surveillance/report capabilities (2) is adaptable for EMR systems (3) approved for intravenous (IV) insulin infusion, IV–subcutaneous (SQ) transition, SQ insulin, hospital-to-home transitions, and outpatient SQ insulin management (4) increased nurses’ satisfaction (5) cost saving</li>
 <li>EndoTool system (Monarch Medical Technologies): Provides clinical decision support for IV insulin, IV-to-SQ transition, and SQ insulin for pediatric and adult patients; is suitable for EMR systems; supports parenteral carbohydrate calculation; its usage decreases hospital-acquired conditions</li>
 <li>GlucoStabilizer (Medical Decision Network): Network-based software solution that enables automatic IV insulin drip rate calculation; it is also approved for IV–SQ transitions</li>
 <li>Core Diabetes App (Transformative Med): Helps the HCPs to calculate insulin dose, but the app does not make automatic changes to the dose; it can be integrated into EMR systems; it provides help with IV insulin rates, IV-to-SQ transitions, and SQ insulin initial doses</li>
</ul>
<p>Technologies to assist in outpatient insulin dosing: These systems are not intended to be used as a substitute for professional medical advice</p>
<ul>
 <li><strong>Basal insulin titration systems</strong>: 
  <ul>
   <li>Insulia (Voluntis): Shares reports with HCPs; patients receive educational coaching messages and safety rules for hypoglycemia management (type 2 diabetes [T2D]/long-acting insulin dosing/manual entry/mobile app + web-based portal)</li>
   <li>iSage Rx (Amalgam): HCPs can choose which algorithm to use for titration and can access reports (T2D/long-acting insulin dosing/manual entry/mobile app + web-based portal)</li>
   <li>Mobile Insulin Dosing System (MIDS, Glooko): Patient can self-adjust basal insulin after the HCPs install the treatment plan using MIDS (T2D/long-acting insulin dosing/automatic/mobile app + web-based platform)</li>
   <li><strong>My Dose Coach</strong>&nbsp;(Sanofi, Approved by authorities and available in KSA &amp; KWT) The HCPs can create an individualized dose plan on a Web-based portal. Patients need to manually input their fasting blood glucose levels and insulin dosing once daily, along with any incidences of hypoglycemia in the mobile app. Based on these inputs, the app tells users whether and by how much to adjust their dose (shares reports with HCPs/T2D/long-acting insulin dosing/manual entry/mobile app + web-based portal)<br>
     &nbsp;</li>
  </ul></li>
 <li><strong>Mealtime insulin calculators:</strong>
  <ul>
   <li>InPen (Companion Medical): Shares reports with HCPs, sends reminders, and monitors insulin temperature (insulin on board [IOB]) (type 1 diabetes [T1D] and T2D/rapid-acting insulin dosing/manual entry/pen connected with app by Bluetooth)</li>
   <li>Accu-Chek Bolus Advisor (Roche): Shares reports with HCPs and calculates IOB (T1D and T2D/rapid-acting insulin dosing/manual entry/mobile app + web-based portal)</li>
  </ul></li>
</ul>

Insulin titration and technology-based solutions

My Dose Coach Inquiry

<h2>Hypoglycemia<sup>1</sup></h2>
<h3>Symptoms of Low Blood Glucose</h3>
<p>An individual may not always recognize symptoms of low blood glucose.</p>
<p>These common symptoms, and others, may indicate low blood glucose.</p>
<p>Hypoglycemia (low blood glucose) happens when blood glucose drops below optimal levels.</p>
<p>A blood glucose of 70 mg/dl or less is considered hypoglycemia usually occurs in people who take insulin or certain diabetes pills; although, it can happen to anyone with diabetes.</p>

<h2>Hypoglycemia may result from one or more of the following:</h2>
<ul>
 <li>Taking too much diabetes medication</li>
 <li>Delaying or skipping a meal</li>
 <li>Not eating enough carbohydrate at your meal</li>
 <li>Exercising harder or more than usual</li>
</ul>

<h2>Follow the Rule of 15 - to treat hypoglycemia</h2>
<h3>Step 1</h3>
<p>Check your blood glucose. If it is below 70 mg/dl, eat or drink 15 grams of carbohydrate. Examples include:</p>
<ul>
 <li>3-4 glucose tablets</li>
 <li>15-gram tube of glucose gel or liquid</li>
 <li>1/2 cup fruit juice</li>
 <li>1/2 cup regular soda</li>
</ul>
<p>If you cannot check your blood glucose right away, eat or drink 15 grams of carbohydrate just to be safe.</p>
<h3>Step 2</h3>
<p>Wait&nbsp;<strong>15 minutes</strong>&nbsp;- this is important! It takes 15 minutes to feel better, no matter how much carbohydrate you use to treat the low blood glucose.</p>
<h3>Step 3</h3>
<p>Check your blood glucose again. If your blood glucose level is still low (&lt;70 mg/dl), or if you still have symptoms, repeat steps 1 through 3.</p>
<p>If you still have a low blood glucose after the three checks, call 997.</p>
<h3>Step 4</h3>
<p>Check your blood glucose one hour after treatment, as additional carbohydrate may be needed if you don't have a meal or snack planned. (Blood glucose levels tend to drop about one hour after treatment.).py: Up-titration to 150 mg Q2W occurred at week 12 in 17% of patients who did not achieve their predefined target LDL-C at week 8. Overall, 84% had clinical ASCVD.<sup>1</sup></p>

Hypoglycemia

<h2>What is Diabetes?</h2>
<p>Diabetes is a chronic (long-lasting) disease that affects how your body turns food into energy.</p>
<p>Most of the food you eat is broken down into sugar (also called glucose) and released into your bloodstream. Your pancreas makes a hormone called insulin, which acts like a key to let the blood sugar into your body's cells for use as energy.</p>
<p>If you have diabetes, your body either doesn't make enough insulin or can't use the insulin it makes as well as it should. When there isn't enough insulin or cells stop responding to insulin, too much blood sugar stays in your bloodstream, which over time can cause serious health problems, such as heart disease, vision loss, and kidney disease.</p>
<p>There isn't a cure yet in diabetes, but healthy lifestyle habits, taking medicine as needed, getting diabetes self-management education, and keeping appointments with your health care team can greatly reduce its impact on your life.</p>

<h2>Types of Diabetes<sup>1</sup></h2>
<p>There are three main types of diabetes: type 1, type 2, and gestational diabetes (diabetes while pregnant).</p>

<h2>Type 1 Diabetes</h2>
<p>is caused by an autoimmune reaction (the body attacks itself by mistake) that stops your body from making insulin. About 5% of the people who have diabetes have type 1. Symptoms of type 1 diabetes often develop quickly. It's usually diagnosed in children, teens, and young adults. If you have type 1 diabetes, you'll need to take insulin every day to survive. Currently, no one knows how to prevent type 1 diabetes.</p>

<h2>Type 2 Diabetes</h2>
<p>your body doesn't use insulin well and is unable to keep blood sugar at normal levels. Most people with diabetes -9 and 10- have type 2 diabetes. It develops over many years and is usually diagnosed in adults (though increasingly in children, teens, and young adults). You may not notice any symptoms, so it's important to get your blood sugar tested if you're at risk. Type 2 diabetes can be prevented or delayed with healthy lifestyle changes, such as losing weight if you're overweight, healthy eating, and getting regular physical activity.</p>

<h2>Gestational Diabetes</h2>
<p>develops in pregnant women who have never had diabetes. If you have gestational diabetes, your baby could be at higher risk for health complications. Gestational diabetes usually goes away after your baby is born but increases your risk for type 2 diabetes later in life. Your baby is more likely to become obese as a child or teen, and more likely to develop type 2 diabetes later in life too.</p>

<h2>Symptoms of Diabetes?<sup>2</sup></h2>
<p>People who think they might have diabetes must visit a physician for diagnosis. They might have SOME or NONE of the following symptoms:</p>
<ul>
 <li>Frequent urination</li>
 <li>Excessive thirst</li>
 <li>Unexplained weight loss</li>
 <li>Extreme hunger</li>
 <li>Sudden vision changes</li>
 <li>Tingling or numbness in hands or feet</li>
 <li>Feeling very tired much of the time</li>
 <li>Very dry skin</li>
 <li>Sores that are slow to heal</li>
 <li>More infections than usual</li>
</ul>
<p>Nausea, vomiting, or stomach pains may accompany some of these symptoms in the abrupt onset of insulin-dependent diabetes now called Type 1 diabetes.</p>

<h2>Who's at Risk?<sup>3</sup></h2>
<p>You're at risk for developing type 2 diabetes if you:</p>
<ul>
 <li>Have prediabetes</li>
 <li>Are overweight</li>
 <li>Are 45 years or older</li>
 <li>Have a parent, brother, or sister with type 2 diabetes</li>
 <li>Are physically active less than 3 times a week</li>
 <li>Have ever had gestational diabetes (diabetes during pregnancy) or given birth to a baby who weighed more than 9 pounds</li>
 <li>Are African American, Hispanic/Latino American, American Indian, or Alaska Native (some Pacific Islander and Asian Americans are also at higher risk)</li>
</ul>
<p>You can prevent or delay type 2 diabetes with simple, proven lifestyle changes such as losing weight if you're overweight, eating healthier, and getting regular physical activity.</p>

<table border="1" cellpadding="1" cellspacing="1" style="width:100%;">
 <tbody>
  <tr>
   <td style="width: 20%; background-color: rgb(172, 180, 22);">
    <p><span style="color:#ffffff;"><strong>Result</strong></span></p></td>
   <td style="width: 20%; background-color: rgb(172, 180, 22);">
    <p><span style="color:#ffffff;"><strong>A1C Test</strong></span></p></td>
   <td style="width: 20%; background-color: rgb(172, 180, 22);">
    <p><span style="color:#ffffff;"><strong>Fasting Blood Sugar Test</strong></span></p></td>
   <td style="width: 20%; background-color: rgb(172, 180, 22);">
    <p><span style="color:#ffffff;"><strong>Glucose Tolerance Test</strong></span></p></td>
   <td style="width: 20%; background-color: rgb(172, 180, 22);">
    <p><span style="color:#ffffff;"><strong>Random Blood Sugar Test</strong></span></p></td>
  </tr>
  <tr>
   <td>
    <p><span style="color:#484995;"><strong>Normal</strong></span></p></td>
   <td>
    <p><span style="color:#484995;">Below 5.7%</span></p></td>
   <td>
    <p><span style="color:#484995;">99&nbsp;mg/dL or below</span></p></td>
   <td>
    <p><span style="color:#484995;">140 mg/dL or below</span></p></td>
   <td>
    <p>&nbsp;</p></td>
  </tr>
  <tr>
   <td>
    <p><span style="color:#484995;"><strong>Prediabetes</strong></span></p></td>
   <td>
    <p><span style="color:#484995;">5.7 - 6.4%</span></p></td>
   <td>
    <p><span style="color:#484995;">100 - 125 mg/dL</span></p></td>
   <td>
    <p><span style="color:#484995;">140 - 190 mg/dL</span></p></td>
   <td>
    <p>&nbsp;</p></td>
  </tr>
  <tr>
   <td>
    <p><span style="color:#484995;"><strong>Diabetes</strong></span></p></td>
   <td>
    <p><span style="color:#484995;">6.5% or above</span></p></td>
   <td>
    <p><span style="color:#484995;">126 mg/dL or above</span></p></td>
   <td>
    <p><span style="color:#484995;">200 mg/dL or above</span></p></td>
   <td>
    <p><span style="color:#484995;">200 mg/dL or above</span></p></td>
  </tr>
 </tbody>
</table>

About Diabetes

To read the full content, activate your Sanofi Campus account. Please confirm your email address in the email you received.

If you didn't receive our first email at <strong>{email}</strong> to confirm your account you can request a new one below. If you don't see it, you may need to <strong>check your spam</strong> folder.

This information will only be used to validate your account and will not be distributed.

title

Before starting exploring, we can suggest you <strong>specific and relevant content</strong>

Title

This website is for healthcare professionals only

Welcome to BP Sanofi Campus

Create new password

To offer you a personalised experience, you must

Your profile is incomplete

The ADCT gives a measure of how controlled the eczema is. Answer these 6 simple questions with your patient to find the ADCT score. It will indicate proper course of action.

Atopic dermatitis, a type of eczema, may be affecting your Patient's life in more ways than you know.

Take the Atopic Dermatitis Control Test (ADCT)

Enjoy more exclusive content{newline}by <a>registering today</a>

Already have an account? <a>Sign in here</a>

Best practices on optimising patient care

Get a customised view of the topics that you're interested in, along with the ability to save content to watch or read at a later date.

Unlimited access to premier content, white papers, case studies, research papers, webinars, training, and up-to-date scientific medical resources.

Personalised content based on your areas of interest

Connect and stay up-to-date with peers in your area of speciality and topics of interest through free events and leadership forums.

Please sign in to continue and read the full article

Please sign up to continue reading the full article.

We respect your privacy and will not share your information with any 3rd parties.

Topical guides written specifically for patients

Unlimited access to the latest patient guide guides and resources. Share content with your patients with easy-to-use online tools.

Please complete your profile to read the content.

Your profile is not validated yet. Please verify your inbox.

Restricted Access

We can't find the page you're looking for

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

You are about to leave Sanofi Campus website.

You are now leaving this site to visit a partner website.

Thank you for visiting COPD Sanofi Campus.

This website is for healthcare professionals only.

Welcome to COPD Sanofi Campus.

Welcome to COPD Sanofi Campus

Welcome to CSU Sanofi Campus

Please refresh the page to access the content

Sorry, something went wrong

We're usually a treasure chest of knowledge, but we couldn't find what you're looking for.

We were unable to find what you're searching for

You are about to leave Campus.sanofi/uk.

Images from <a>iStockphoto.com</a>, <b>Fotolia.de</b>, <c>gettyimages.de</c>, <d>pexels.com</d> and <e>photocase.de</e> were used for our websites.

<strong>Thank you for registering. Before we get started, we need to confirm your email address to ensure that we have the correct information.</strong><br></br><br></br><br></br>

<strong>Please follow these steps to complete your registration:</strong><br></br><br></br>

<strong>Would you like to receive future text messages about Beyfortus updates?</strong>

<strong>Sanofi is here to help support your patients, their families, and caregivers.</strong><br></br><br></br>For more information regarding Beyfortus®, call <a.callPhoneNumberBeyfortus>1-855-BEYFORTUS (1-855-239-3678)</a.callPhoneNumberBeyfortus> or sign up below to receive the latest updates via email or text.<br></br><br></br><strong>All fields are required.</strong>

Would you like to learn more about Beyfortus<sup>®</sup> (nirsevimab-alip) 50 mg and 100 mg injection?<br></br>Leave us your contact details, and a Sanofi representative will be in touch.<br></br><br></br><strong>All fields are required.</strong>

<strong>Would you also like to receive future messages and updates about Beyfortus?</strong>

Do you want to participate in the Beyfortus Reservation Program?

What information are you interested in learning more about? (Optional)

Are you enrolled in CENRIFKI REMS?

Request a visit from your local ALPROLIX representative to learn more.<br></br><br></br>Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>.<br></br><br></br><strong>All fields are required.</strong>

Request a visit from your local ALTUVIIIO representative to learn more.<br></br><br></br>Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>.<br></br><br></br><strong>All fields are required.</strong>

Request a visit from your local QFITLIA representative to learn more.<br></br><br></br>Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>.<br></br><br></br><strong>All fields are required.</strong>

Sign up to schedule an office visit with your ALPROLIX® Representative or receive updates about ALPROLIX.<br></br><br></br>Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>.<br></br><br></br><strong>All fields are required.</strong>

Sign up to schedule an office visit with your local Sanofi representative and/or to receive updates about Qfitlia.<br></br><br></br>Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>.<br></br><br></br><strong>All fields are required (unless otherwise specified).</strong>

All fields are required. (unless otherwise specified)

This site is intended for healthcare professionals only and contains information on Sanofi medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs.

Welcome to Sanofi Campus

Welcome to ITP Sanofi Campus

This content is only available to registered users. Please sign in or register to view this content.

Please Sign In

Email verification

You're seeing a preview of the portal. Clear your cookies (by closing your browser window for example) to go back to public mode.

We've updated our privacy notice to better protect your data and enhance your experience. Please take a moment to review the changes by <privacyNewTab>clicking here</privacyNewTab>. Your privacy matters for us. <br></br>Please click on continue to confirm you have read the new privacy notice.

Privacy Notice Update

Communication consent

My consents

Password

Confirm password

{resultsCount, plural, one {result} other {results}}

Please log in to access to the results

You need to sign-in to your account in order to access medical content.

Please Log In

To access the results, please register in under 1 minute

You are now leaving the Sanofi content section of our site and entering the external medical bibliographic search content section.

You are entering to the External Scientific Content Site

You are now leaving the external medical bibliographic search section of our site and entering the Sanofi content section.

Integrated Diabetes Care

Latest Resources